Simultaneous treatment of hypertension and opiate withdrawal using an alpha 2-adrenergic agonist
Bell, C.C.
Journal of the National Medical Association 75(1): 89-93
1983
ISSN/ISBN: 0027-9684 PMID: 6131140 Document Number: 215627
This report describes the treatment of a Viet Nam veteran with an α(2)-adrenergic agonist (clonidine) for hypertension which had an additional beneficial effect of allowing withdrawal in ten days from 20 mg of methadone a day with minimal withdrawal symptoms.
Document emailed within 1 workday
Related Documents
Skuza, G.; Kolasiewicz, W. 2001: Repeated treatment with SA4503, a selective sigma1 receptor agonist, up-regulates alpha-adrenergic system. a behavioral study Polish Journal of Pharmacology 53(5): 547-550De Leeuw, P.W.; Birkenhäger, W.H. 1983: Alpha-adrenergic blockade in the treatment of essential hypertension Netherlands Journal of Medicine 26(9): 274-282
Cooper, B.; Handin, R.I.; Young, L.H.; Alexander, R.W. 1978: Agonist regulation of the human platelet alpha-adrenergic receptor Nature 274(5672): 703-706
Taraphder, A. 2014: Alpha Adrenergic Blockers in the Treatment of Hypertension--A Nephrologist's Perspective Journal of the Association of Physicians of India 62(9 Suppl): 30-33
Renouard, A.; Widdowson, P.S.; Millan, M.J. 1994: Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes Journal of Pharmacology and Experimental Therapeutics 270(3): 946-957
Campanacci, L.; Bellini, G.; Battilana, G.; Rigoni, A.; Cosenzi, A.; Carretta, R.; Puppis, E.; Pierini, B.; Faccini, L. 1984: Central alpha-adrenergic agonist antihypertensive drugs and renal failure La Clinica Terapeutica 109(4): 301-309
Muga, R.; Tor, J.; Forteza-Rei, J.; Jacas, C.; Altés, J.; Mestre, L. 1990: Comparative effectiveness of alpha-2 adrenergic agonists (clonidine-guanfacine) in the hospital detoxification of opiate addicts Medicina Clinica 94(5): 169-172
Christ, G.J.; Brink, P.R.; Zhao, W.; Moss, J.; Gondré, C.M.; Roy, C.; Spray, D.C. 1993: Gap junctions modulate tissue contractility and alpha 1 adrenergic agonist efficacy in isolated rat aorta Journal of Pharmacology and Experimental Therapeutics 266(2): 1054-1065
Ishikawa, K.; Kakegawa, T.; Suzuki, M. 1986: Plasma thyrotrophin (TSH) response to intrahypothalamic injection of an alpha 2-adrenergic receptor agonist (clonidine) Acta Endocrinologica 111(1): 25-29
Tsai, B.S.; Lefkowitz, R.J. 1979: Agonist-specific effects of guanine nucleotides on alpha-adrenergic receptors in human platelets Molecular Pharmacology 16(1): 61-68
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
Pir'ova, B. 1987: Alpha-adrenergic control of kidney function. its significance for the pathogenesis and treatment of arterial hypertension Vutreshni Bolesti 26(6): 12-18
Zonis, B.Ia.; Brin, V.B. 1979: Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane Terapevticheskii Arkhiv 51(11): 28-30
Jagadeesh, G.; Deth, R.C. 1988: Phorbol ester-induced modulation of agonist binding to alpha-1 adrenergic receptors in bovine aortic membranes Journal of Pharmacology and Experimental Therapeutics 247(1): 196-202
Des Jarlais, D.C.; Hammett, T.M.; Wei, L.; Van, L.K.; Donghua, M.; Ngu, D. 2004: Opiate agonist maintenance treatment for injecting drug user peer educators Addiction 99(10): 1355-1356
Gudeman, J.E.; Shader, R.I.; Ryan, J.; Rolde, E.J. 1972: Preliminary experiences with the treatment of opiate addiction by methadone withdrawal Connecticut Medicine 36(3): 137-142
Quintin, L.; Ghignone, M.; Pujol, J.F. 1987: The ability of the alpha 2-adrenergic agonist clonidine to suppress central noradrenergic hyperactivity secondary to hemodynamic or environmental stimuli Journal of Cardiovascular Pharmacology 10(Suppl 12): S128-S134
Tsai, B.S.; Lefkowitz, R.J. 1978: Agonist-specific effects of monovalent and divalent cations on adenylate cyclase-coupled alpha adrenergic receptors in rabbit platelets Molecular Pharmacology 14(4): 540-548
Jagadeesh, G.; Deth, R.C. 1992: Phorbol ester and staurosporine modulation of antagonist and agonist binding to alpha-2 adrenergic receptors: differential influence on Na+ versus guanylylnucleotide regulation Journal of Pharmacology and Experimental Therapeutics 262(2): 775-783
Leshchinskiĭ, L.A.; Logacheva, I.V.; Nikolaeva, V.A.; Plastinina, R.A.; Polischuk, M.A. 1983: Effect of the combined administration of alpha- and beta-adrenergic blockaders (propranolol and phentolamine) on central and renal hemodynamics during the treatment of patients with arterial hypertension Terapevticheskii Arkhiv 55(9): 48-51